Schwerin Boyle Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-60,000
Closed -$7.45M 49
2021
Q2
$7.45M Hold
60,000
0.61% 38
2021
Q1
$7.09M Hold
60,000
0.63% 37
2020
Q4
$7.03M Hold
60,000
0.66% 40
2020
Q3
$6.24M Hold
60,000
0.72% 36
2020
Q2
$5.5M Hold
60,000
0.69% 34
2020
Q1
$5.41M Hold
60,000
0.76% 36
2019
Q4
$6.81M Hold
60,000
0.65% 37
2019
Q3
$6.52M Hold
60,000
0.67% 39
2019
Q2
$5.84M Hold
60,000
0.61% 41
2019
Q1
$5.46M Hold
60,000
0.6% 39
2018
Q4
$5.46M Hold
60,000
0.69% 40
2018
Q3
$5.9M Hold
60,000
0.63% 43
2018
Q2
$5.14M Hold
60,000
0.56% 44
2018
Q1
$4.81M Hold
60,000
0.53% 48
2017
Q4
$4.84M Hold
60,000
0.53% 43
2017
Q3
$4.67M Hold
60,000
0.53% 46
2017
Q2
$5.33M Hold
60,000
0.63% 42
2017
Q1
$4.83M Hold
60,000
0.59% 44
2016
Q4
$4.27M Hold
60,000
0.53% 45
2016
Q3
$5.18M Hold
60,000
0.72% 41
2016
Q2
$5.21M Hold
60,000
0.75% 38
2016
Q1
$4.5M Hold
60,000
0.63% 44
2015
Q4
$4.62M Hold
60,000
0.64% 43
2015
Q3
$4.02M Hold
60,000
0.58% 43
2015
Q2
$4.45M Hold
60,000
0.58% 42
2015
Q1
$4.68M Hold
60,000
0.66% 40
2014
Q4
$4.33M Hold
60,000
0.59% 40
2014
Q3
$3.72M Hold
60,000
0.52% 43
2014
Q2
$3.83M Hold
60,000
0.55% 40
2014
Q1
$3.69M Hold
60,000
0.53% 43
2013
Q4
$3.44M Hold
60,000
0.48% 45
2013
Q3
$3.19M Hold
60,000
0.48% 45
2013
Q2
$3.09M Buy
+60,000
New +$2.97M 0.5% 44

Other funds holding MDT

Schwerin Boyle Capital Management's MDT Position: Q3 2021 in Review

Schwerin Boyle Capital Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 60,000 shares — an estimated $7.45M sold.

Schwerin Boyle Capital Management first reported a position in MDT in Q2 2013 and held it in 33 quarters. The position peaked at $7.45M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Schwerin Boyle Capital Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Schwerin Boyle Capital Management sold 60,000 Medtronic shares in Q3 2021, an estimated $7.45M.
  • Schwerin Boyle Capital Management first reported a position in Medtronic in Q2 2013 and held it in 33 quarters.
  • Schwerin Boyle Capital Management's Medtronic position peaked at $7.45M in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Schwerin Boyle Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.